Klebsiella pneumoniae in Intra-Abdominal Infections: Prevalence Data
Klebsiella pneumoniae accounts for approximately 10-26% of intra-abdominal infections, with significant geographic variation—ranging from 9-17% globally to as high as 26% in certain Asian populations, particularly Taiwan.
Regional Prevalence Patterns
Taiwan (Highest Documented Rates)
The most specific data comes from Taiwan's SMART surveillance program (2002-2006), where Klebsiella species represented 26.2% of all aerobic and facultative gram-negative bacilli isolated from intra-abdominal infections, making it the single most common pathogen—even more prevalent than E. coli (7.1%) in this population 1. This striking finding contradicts the typical global pattern where E. coli predominates.
Global and Other Regional Data
More broadly representative studies show lower but still substantial rates:
China (2008-2013): K. pneumoniae accounted for 16.9% of isolates from complicated intra-abdominal infections, second only to E. coli (47.6%) 2
Somalia (tertiary hospital): K. pneumoniae represented 21.5% of isolates, again second to E. coli (40%) 3
China ICU patients: K. pneumoniae comprised 10.2% of isolates from complicated intra-abdominal infections 4
India (tertiary care): K. pneumoniae accounted for 9.2% of intra-abdominal infection isolates 5
Organ-Specific Distribution
The prevalence varies substantially by anatomic site of infection 6:
- Liver infections: K. pneumoniae constitutes 45.2% of pathogens (highest proportion)
- Gall bladder, pancreas, peritoneum, colon: 15.2-20.8%
- Appendix: <10% (lowest proportion)
This organ-specific tropism is clinically important—if you're treating a liver abscess or biliary tract infection, K. pneumoniae becomes the predominant concern rather than E. coli 6, 7.
Clinical Significance Beyond Prevalence
Resistance Patterns
The clinical impact of K. pneumoniae extends beyond its prevalence due to concerning resistance profiles:
- ESBL production rates: 36.2% in K. pneumoniae (lower than E. coli's 65.7%) 6
- Carbapenem resistance: K. pneumoniae shows higher carbapenem resistance rates compared to E. coli in bloodstream infections associated with intra-abdominal sources 8
- In Taiwan, ESBL rates among K. pneumoniae from intra-abdominal infections were 7% (2009 data) 1
Mortality Impact
Patients with K. pneumoniae intra-abdominal infections present with more severe disease (higher Pitt and SOFA scores) compared to E. coli infections, though 30-day mortality rates are comparable between the two pathogens 8. The global burden analysis identified intra-abdominal infections as one of the three primary infection types caused by K. pneumoniae, accounting for nearly 90% of K. pneumoniae-related deaths 9.
Key Clinical Caveats
Geographic variation is substantial. The 26% prevalence in Taiwan represents an outlier—most settings will see 10-17% prevalence. Always prioritize local antibiogram data over these general figures when selecting empiric therapy 10.
Community-acquired versus healthcare-associated infections matter. These prevalence figures primarily reflect mixed populations. Healthcare-associated intra-abdominal infections show different resistance patterns and may have different pathogen distributions 10.
The infection source determines pathogen likelihood. Don't apply overall prevalence figures blindly—a liver abscess has vastly different microbiology than appendicitis 6.